Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Pain management devices comprise a variety of instruments used for relieving pain. These devices are advantageous for long-term treatment of pain especially for chronic conditions such as cancer and arthritis. Pain can be controlled with the use of electrical currents, analgesic pumps, radiofrequency ablation or minimally invasive procedures such as neurostimulation.

Statistics:

The global pain management devices market is estimated to account for US$ 17,004.2 Mn in terms of value by the end of 2027.

Global Pain Management Devices Market: Drivers

Increasing prevalence of osteoarthritis is expected to propel growth of the global pain management devices market over the forecast period. For instance, according to the study ‘Osteoarthritis in Europe: Impact on health status, work productivity and use of pharmacotherapies in five European countries’ that examined the impact of peripheral joint osteoarthritis across five European countries, UK (43.6%), France, (25.6%), Germany, (15.2%), Spain, (8.4%), and Italy (7.1%) recorded high prevalence of peripheral joint osteoarthritis, with majority of cases aging 55-74 years.

Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the United Nations April 2019 data, the share of geriatric population in India is expected to increase to nearly 20% in 2050.

Statistics:

North America held dominant position in the global pain management devices market in 2019, accounting for 49.8% share in terms of value, followed by Europe and Asia Pacific, respectively

Figure 1: Global Pain Management Devices Market Share (%) Value, By Region, 2019

Pain Management Devices  | Coherent Market Insights

Global Pain Management Devices Market: Restraints

Side effects of pain management devices are expected to hinder growth of the market. Use of neurostimulators may lead to increased risk of infection and conditions where the blood for hematoma may leak into the area where the neurostimulator is placed. Device complications may also require additional surgical intervention such as relocation, repair or replacement of certain parts.

Moreover, imposition of an excise duty on medical devices is also expected to limit growth if the market. For instance, in the U.S., Affordable Healthcare for America Act was implemented in 2010. One of the clauses imposes an excise duty of 2.5% on all medical devices.

request-sample

Pain Management Devices Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 5,745.0 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 14.6% 2027 Value Projection: US$ 17,004.2 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
  • Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: North Africa, Central Africa, South Africa
Segments covered:
  • By Product Type:
    • Electrical Stimulators: TENS, Others
    • Radiofrequency Ablation
    • Analgesic Pumps: Intrathecal, External.
    • Neurostimulation Devices: Spinal Cord Stimulation, Sacral Stimulation, Deep Brain Stimulation.
Companies covered:

Baxter International Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Codman and Shurtleff, Inc., DJO Global LLC, NeuroMetrix, Inc., Hospira Inc., Kimberly-Clark Corporation, Medtronic, Plc, Smiths Medical, Axonics Modulation Technologies, Inc., NeuroSigma, Inc., and Abbott

Growth Drivers:
  • Increasing prevalence of chronic disorders
  • Approval and launch of new products
Restraints & Challenges:
  • Product recall

Global Pain Management Devices Market: Opportunities 

Increasing prevalence of cancer is expected to offer lucrative growth opportunities for players in the global pain management devices market. For instance, according to the World Health Organization, around 18.1 million new cases and 9.6 million deaths were registered due to cancer worldwide in 2018.

Moreover, increasing investment R&D of devices is also expected to aid in growth of the market. For instance, in July 2019, Tivic Health Systems, a developer of sinus pain relief devices, raised US$ 8 million in seed funding, which will be utilized to market the launch of its ClearUP device.

Statistics:

The global pain management devices market was valued at US$ 5,745.0 Mn in 2019 and is forecast to reach a value of US$ 17,004.2 Mn by 2027 at a CAGR of 14.7% between 2020 and 2027.

Figure 2: Global Pain Management Devices Market Value (US$ Mn), 2016 – 2027

Pain Management Devices  | Coherent Market Insights

Market Trends/Key Takeaways

Increasing prevalence of neurological disorders is boosting growth of the market. For instance, according to Public Health England’s Statistical commentary: dementia profile, April 2019 update, in U.K. geriatric population, the prevalence rate of recorded dementia was 4.3 per 100 registered general practice population in 2018, which accounted for 448,300 cases with dementia, 10,200 more than in 2017.

Moreover, R&D in non-invasive pain treatment devices is also expected to aid in growth of the market. For instance, in April 2019, researchers from the University of Rome Tor Vergata, Rome, Italy reviewed the efficacy of the Scrambler therapy (ST), which is an electro-analgesia therapy for noninvasive treatment of chronic neuropathic and cancer pain.

Global Pain Management Devices Market: Competitive Landscape

Major players operating in the global pain management devices market include, Baxter International Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Codman and Shurtleff, Inc., DJO Global LLC, NeuroMetrix, Inc., Hospira Inc., Kimberly-Clark Corporation, Medtronic, Plc, Smiths Medical, Axonics Modulation Technologies, Inc., NeuroSigma, Inc., and Abbott  

Global Pain Management Devices Market: Key Developments

Major players in the market are focused on approval and launch of new devices to expand their product portfolio. For instance, in April 2019, NeuroSigma, Inc. received the U.S. FDA marketing approval for its Monarch external Trigeminal Nerve Stimulation (eTNS) System for the treatment of attention deficit hyperactivity disorder. 

Pain Management Devices are used long-term treatment of pain especially for chronic conditions such as cancer and arthritis. Electrical currents, analgesic pumps, radiofrequency ablation or minimally invasive procedures such as neurostimulation are used for treating pain. Increasing incidence and prevalence of chronic diseases along with increasing product approval and launch is expected to drive the market growth during the forecast period. Furthermore, increasing investment R&D of devices along with increasing demand from developing economies is also anticipated to assist the market growth.

Key features of the study:

  • This report provides in-depth analysis of the Global Pain Management Devices market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Pain Management Devices market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Baxter International Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Codman and Shurtleff, Inc., DJO Global LLC, NeuroMetrix, Inc., Hospira Inc., Kimberly-Clark Corporation, Medtronic, Plc, Smiths Medical, Axonics Modulation Technologies, Inc., NeuroSigma, Inc., and Abbott
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Pain Management Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Pain Management Devices market

Detailed Segmentation:

  • Global Pain Management Devices Market, By Product Type:
    • Electrical Stimulators
      • TENS
      • Others
    • Radiofrequency Ablation
    • Analgesic Pumps
      • Intrathecal
      • External
    • Neurostimulation Devices
      • Spinal Cord Stimulation
      • Sacral Stimulation
      • Deep Brain Stimulation
  • Global Pain Management Devices Market, By Region:
    • North America
      • By Product Type:
        • Electrical Stimulators
          • TENS
          • Others
        • Radiofrequency Ablation
        • Analgesic Pumps
          • Intrathecal
          • External
        • Neurostimulation Devices
          • Spinal Cord Stimulation
          • Sacral Stimulation
          • Deep Brain Stimulation
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Electrical Stimulators
          • TENS
          • Others
        • Radiofrequency Ablation
        • Analgesic Pumps
          • Intrathecal
          • External
        • Neurostimulation Devices
          • Spinal Cord Stimulation
          • Sacral Stimulation
        • Deep Brain Stimulation
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Electrical Stimulators
          • TENS
          • Others
        • Radiofrequency Ablation
        • Analgesic Pumps
          • Intrathecal
          • External
        • Neurostimulation Devices
          • Spinal Cord Stimulation
          • Sacral Stimulation
        • Deep Brain Stimulation
      • By Country
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Electrical Stimulators
          • TENS
          • Others
        • Radiofrequency Ablation
        • Analgesic Pumps
          • Intrathecal
          • External
        • Neurostimulation Devices
          • Spinal Cord Stimulation
          • Sacral Stimulation
        • Deep Brain Stimulation
      • By Country
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Electrical Stimulators
          • TENS
          • Others
        • Radiofrequency Ablation
        • Analgesic Pumps
          • Intrathecal
          • External
        • Neurostimulation Devices
          • Spinal Cord Stimulation
          • Sacral Stimulation
        • Deep Brain Stimulation
      • By Country
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Electrical Stimulators
          • TENS
          • Others
        • Radiofrequency Ablation
        • Analgesic Pumps
          • Intrathecal
          • External
        • Neurostimulation Devices
          • Spinal Cord Stimulation
          • Sacral Stimulation
        • Deep Brain Stimulation
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Baxter International Inc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • B. Braun Melsungen AG
    • Boston Scientific Corporation
    • Codman and Shurtleff, Inc.
    • DJO Global LLC
    • NeuroMetrix, Inc.
    • Hospira Inc.
    • Kimberly-Clark Corporation
    • Medtronic, Plc.
    • Smiths Medical
    • Axonics Modulation Technologies, Inc.
    • NeuroSigma, Inc.
    • Abbott
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Country
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
    • COIVID19 Impact on the market
  4. Global Pain Management Devices Market, By Product Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Electrical Stimulators
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • TENS
        • Others
    • Radiofrequency Ablation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Analgesic Pumps
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Intrathecal
        • External
    • Neurostimulation Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Spinal Cord Stimulation
        • Sacral Stimulation
        • Deep Brain Stimulation
  5. Global Pain Management Devices Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  6. Competitive Landscape
    • Company Profiles
      • Baxter International Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • B. Braun Melsungen AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Codman and Shurtleff, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • DJO Global LLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • NeuroMetrix, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hospira Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Kimberly-Clark Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtronic, Plc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Smiths Medical
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Axonics Modulation Technologies, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • NeuroSigma, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abbott
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  7. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 22 market data tables and 14 figures on “Pain Management Devices Market - Global forecast to 2027”.

Frequently Asked Questions

The Global Pain Management Devices market size was valued at US$ 5,745.0 million in 2019 and is estimated to exhibit a CAGR of 14.6% between 2020 and 2027.
Neurostimulation Devices segment held the major market share in 2019 owing to an increasing prevalence of chronic disorders is expected to propel growth of the market.
Major factor driving the growth of Global Pain Management Devices market during the forecast period increasing prevalence of chronic disorders, increasing research & development , and adoption of expansion strategies from major companies.
Major factors hampering the growth of the Global Pain Management Devices market during the forecast period constitutes of product recall.
North America market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Baxter International Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Codman and Shurtleff, Inc., DJO Global LLC, NeuroMetrix, Inc., Hospira Inc., Kimberly-Clark Corporation, Medtronic, Plc, Smiths Medical, Axonics Modulation Technologies, Inc., NeuroSigma, Inc., and Abbott
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner